CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Orange City, Florida, United States and 93 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Orlando, Florida, United States and 215 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Orlando, Florida, United States and 73 other locations
This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...
Phase 3
Orlando, Florida, United States and 119 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:Find the recommended dose o...
Phase 1, Phase 2
Orlando, Florida, United States and 9 other locations
or obinutuzumab) in subjects with relapsed or refractory (R/R) lymphoma. Subjects must have received at least 2 prior lines of therapy, and ...
Phase 1
Lake Mary, Florida, United States and 25 other locations
regimens in participants with relapsed or refractory mantle cell lymphoma (MCL) previously treated either with or without a Bruton's tyrosin...
Phase 2
Winter Haven, Florida, United States and 102 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Orlando, Florida, United States and 29 other locations
patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas who have failed or a...
Phase 1
Orlando, Florida, United States and 29 other locations
of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...
Phase 1, Phase 2
Orlando, Florida, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal